With the analysis among 767 patents, we discovered top 128 key players by total patent application. Bayer Intellectual Property GmbH, Amgen, Inc., Novartis AG are dominant in this area. They take 16.82% of the total patent filing.
Bayer Intellectual Property GmbH
Nordrhein-Westfalen, Germany
Patent: 54
California, United States
Patent: 42
Basel-Stadt, Switzerland
Patent: 33
Mogam Institute For Biomedical Research
Chungcheongnam-do, South Korea
Patent: 30
California, United States
Patent: 27
Harpoon Therapeutics, Inc.
California, United States
Patent: 25
New York, United States
Patent: 24
Berlin, Germany
Patent: 24
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 23
With the analysis among 80 patents, we discovered top 12 start-ups by total patent application. DRAGONFLY Therapeutics, Inc., Noile-Immune Biotech, Inc., Hrain Biotechnology Co. Ltd. are active in this area.
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 23
Noile-Immune Biotech, Inc.
Tokyo-to, Japan
Patent: 13
Hrain Biotechnology Co. Ltd.
Shanghai Shi, China
Patent: 12
California, United States
Patent: 6
Institut National de la Santé et de la Recherche Médicale
Huadao (Shanghai) Biomedical Co., Ltd.
Shanghai Shi, China
Patent: 5
California, United States
Patent: 5
Pennsylvania, United States
Patent: 4
Nanjing CART Medical Technologies Co. Ltd.
Jiangsu Sheng, China
Patent: 3
Nanjing Bioheng Biotech Co., Ltd.
Jiangsu Sheng, China
Patent: 1
With the analysis among related 444 patents applied in the last 5 years. We discover 117 most active companies in this area. The fast-growing Harpoon Therapeutics, Inc., DRAGONFLY Therapeutics, Inc., Amgen, Inc. take 15.99% of patent filing during this period.
Harpoon Therapeutics, Inc.
California, United States
Patent: 25
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 23
California, United States
Patent: 23
Department of Health & Human Services
Lentigen Technology, Inc.
Mogam Institute For Biomedical Research
Chungcheongnam-do, South Korea
Patent: 18
Memorial Sloan Kettering Cancer Center
New York, United States
Patent: 17
Eisai R&D Management Co., Ltd.
Tokyo-to, Japan
Patent: 16
With the analysis among related 444 patents in last 5 years, we discover 82 new entrants. Harpoon Therapeutics, Inc., DRAGONFLY Therapeutics, Inc., Lentigen Technology, Inc. are the most active new entrants in this area.
Harpoon Therapeutics, Inc.
California, United States
Patent: 25
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 23
Lentigen Technology, Inc.
Inovio Pharmaceuticals, Inc.
Pennsylvania, United States
Patent: 13
Noile-Immune Biotech, Inc.
Tokyo-to, Japan
Patent: 13
ZURICH, Switzerland
Patent: 10
Washington, United States
Patent: 10
Cambridgeshire, United Kingdom
Patent: 10
Cambridgeshire, United Kingdom
Patent: 9
Nanjing Legend Biotechnology Co., Ltd.
Jiangsu Sheng, China
Patent: 8
With the analysis among 189 patents, we discovered top 20 universities and scientific research institutions by total patent application. The Johns Hopkins University, President & Fellows of Harvard College, University of Washington are dominant in this area. They take 51.85% of the total patent filing.
The Johns Hopkins University
President & Fellows of Harvard College
Massachusetts, United States
Patent: 6
Washington, United States
Patent: 5
Washington University in St. Louis
Missouri, United States
Patent: 5
Okayama-ken, Japan
Patent: 3
Grenoble University Hospital
Minnesota, United States
Patent: 2
Council of Scientific & Industrial Research